Washington, DC 20006-5349
HELPLINE
MESOTHELIOMA NEWS
Scroll to find news of interest to you, or search by category. The Mesothelioma Applied Research Foundation covers mesothelioma news for patients and their families. Our write-ups are heavily reliant on peer-reviewed medical research studies with input from mesothelioma experts from around the world but are also accessible to non-medical readers.
Andreas Rimner, MD discusses a phase 3 clinical trial that is testing the addition of IMRT (intensity-modulated radiotherapy) to pemetrexed (Alimta)/platinum based therapy for pleural
Sean Drake, MD provides an overview of vaccinations — tetanus, diphtheria and pertussis, hepatitis A, hepatitis B, pneumonia, pneumovax, prevnar 13, shingles, shingrix, influenza (flu),
To honor her 11-year “cancerversary,” Ivana Mihajlovic, a 41-year-old peritoneal mesothelioma warrior, is hosting a Fundraise for Meso event on Saturday, Nov. 21 in Kensington,
Arkadiusz Dudek, MD, PhD, discusses the Phase 2 Nivolumab (Opdivo) + Ramucirumab clinical trial for previously-treated mesothelioma patients. The study is available at Moffitt Cancer
Dr. Paul Sugarbaker joins us for an interview about HIPEC (hyperthermic intraperitoneal chemotherapy) for peritoneal mesothelioma. Paul Sugarbaker, MD, FACS, FRCS, is the Chief of
This year’s Kick Out Mesothelioma 5-Miler & 2.5 Mile Walk will take place Sunday, Nov. 8 at 10:00 AM ET in Portland, Maine. Organized by
The Mesothelioma Applied Research Foundation’s 2020 mesothelioma research grant cycle is now accepting pre-application letters of intent (LOI) until 11:59 PM ET Sunday, Nov. 1, 2020 on proposalCENTRAL.
If you are near one of these locations and are able to take a photo, please email them to us at [email protected]. Here is a
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
